# Vaginal Estriol in Multiple Sclerosis

> **NCT03774407** · PHASE2,PHASE3 · COMPLETED · sponsor: **Texas Tech University Health Sciences Center** · enrollment: 21 (actual)

## Conditions studied

- Multiple Sclerosis
- Neurogenic Bladder

## Interventions

- **DRUG:** vaginal estriol

## Key facts

- **NCT ID:** NCT03774407
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-20
- **Primary completion:** 2020-11-10
- **Final completion:** 2020-11-29
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774407, "Vaginal Estriol in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03774407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*